Literature DB >> 28229394

Epileptic Encephalopathies-Clinical Syndromes and Pathophysiological Concepts.

Markus von Deimling1,2, Ingo Helbig1,2, Eric D Marsh3,4.   

Abstract

Epileptic encephalopathies account for a large proportion of the intractable early-onset epilepsies and are characterized by frequent seizures and poor developmental outcome. The epileptic encephalopathies can be loosely divided into two related groups of named syndromes. The first comprises epilepsies where continuous EEG changes directly result in cognitive and developmental dysfunction. The second includes patients where cognitive impairment is present at seizure onset and is due to the underlying etiology but the epileptic activity may then worsen the cognitive abilities over time. Recent, large-scale exome studies have begun to establish the genetic architecture of the epileptic encephalopathies, resulting in a re-consideration of the boundaries of these named syndromes. The emergence of this genetic architecture has lead to three main pathophysiological concepts to provide a mechanistic framework for these disorders. In this article, we will review the classic syndromes, the most significant genetic findings, and relate both to the pathophysiological understanding of epileptic encephalopathies.

Entities:  

Keywords:  Channelopathy; EEG; Epileptic encephalopathies; Genetics; Interneuronopathy

Mesh:

Year:  2017        PMID: 28229394     DOI: 10.1007/s11910-017-0720-7

Source DB:  PubMed          Journal:  Curr Neurol Neurosci Rep        ISSN: 1528-4042            Impact factor:   5.081


  111 in total

Review 1.  SCN1A mutations in Dravet syndrome: impact of interneuron dysfunction on neural networks and cognitive outcome.

Authors:  Alex C Bender; Richard P Morse; Rod C Scott; Gregory L Holmes; Pierre-Pascal Lenck-Santini
Journal:  Epilepsy Behav       Date:  2012-02-16       Impact factor: 2.937

2.  Mutations in the human ortholog of Aristaless cause X-linked mental retardation and epilepsy.

Authors:  Petter Strømme; Marie E Mangelsdorf; Marie A Shaw; Karen M Lower; Suzanne M E Lewis; Helene Bruyere; Viggo Lütcherath; Agi K Gedeon; Robyn H Wallace; Ingrid E Scheffer; Gillian Turner; Michael Partington; Suzanna G M Frints; Jean-Pierre Fryns; Grant R Sutherland; John C Mulley; Jozef Gécz
Journal:  Nat Genet       Date:  2002-03-11       Impact factor: 38.330

3.  STXBP1-related encephalopathy presenting as infantile spasms and generalized tremor in three patients.

Authors:  Cyril Mignot; Marie-Laure Moutard; Oriane Trouillard; Isabelle Gourfinkel-An; Aurélia Jacquette; Benoit Arveiler; Fanny Morice-Picard; Didier Lacombe; Catherine Chiron; Dorothée Ville; Perrine Charles; Eric LeGuern; Christel Depienne; Delphine Héron
Journal:  Epilepsia       Date:  2011-07-18       Impact factor: 5.864

Review 4.  Ohtahara syndrome: with special reference to its developmental aspects for differentiating from early myoclonic encephalopathy.

Authors:  Shunsuke Ohtahara; Yasuko Yamatogi
Journal:  Epilepsy Res       Date:  2006-07-10       Impact factor: 3.045

5.  Differential effects of a polyalanine tract expansion in Arx on neural development and gene expression.

Authors:  MacLean Pancoast Nasrallah; Ginam Cho; Jacqueline C Simonet; Mary E Putt; Kunio Kitamura; Jeffrey A Golden
Journal:  Hum Mol Genet       Date:  2011-11-22       Impact factor: 6.150

6.  Delineation of cryptogenic Lennox-Gastaut syndrome and myoclonic astatic epilepsy using multiple correspondence analysis.

Authors:  A Kaminska; A Ickowicz; P Plouin; M F Bru; G Dellatolas; O Dulac
Journal:  Epilepsy Res       Date:  1999-08       Impact factor: 3.045

7.  Structural genomic variation in childhood epilepsies with complex phenotypes.

Authors:  Ingo Helbig; Marielle E M Swinkels; Emmelien Aten; Almuth Caliebe; Ruben van 't Slot; Rainer Boor; Sarah von Spiczak; Hiltrud Muhle; Johanna A Jähn; Ellen van Binsbergen; Onno van Nieuwenhuizen; Floor E Jansen; Kees P J Braun; Gerrit-Jan de Haan; Niels Tommerup; Ulrich Stephani; Helle Hjalgrim; Martin Poot; Dick Lindhout; Eva H Brilstra; Rikke S Møller; Bobby P C Koeleman
Journal:  Eur J Hum Genet       Date:  2013-11-27       Impact factor: 4.246

8.  SCN1A testing for epilepsy: application in clinical practice.

Authors:  Shinichi Hirose; Ingrid E Scheffer; Carla Marini; Peter De Jonghe; Eva Andermann; Alica M Goldman; Marcelo Kauffman; Nigel C K Tan; Daniel H Lowenstein; Sanjay M Sisodiya; Ruth Ottman; Samuel F Berkovic
Journal:  Epilepsia       Date:  2013-04-15       Impact factor: 5.864

9.  [Neonatal myoclonic encephalopathy (author's transl)].

Authors:  J Aicardi; F Goutieres
Journal:  Rev Electroencephalogr Neurophysiol Clin       Date:  1978 Jan-Mar

10.  Extending the KCNQ2 encephalopathy spectrum: clinical and neuroimaging findings in 17 patients.

Authors:  Sarah Weckhuysen; Vanja Ivanovic; Rik Hendrickx; Rudy Van Coster; Helle Hjalgrim; Rikke S Møller; Sabine Grønborg; An-Sofie Schoonjans; Berten Ceulemans; Sinead B Heavin; Christin Eltze; Rita Horvath; Gianluca Casara; Tiziana Pisano; Lucio Giordano; Kevin Rostasy; Edda Haberlandt; Beate Albrecht; Andrea Bevot; Ira Benkel; Steffan Syrbe; Beth Sheidley; Renzo Guerrini; Annapurna Poduri; Johannes R Lemke; Simone Mandelstam; Ingrid Scheffer; Marco Angriman; Pasquale Striano; Carla Marini; Arvid Suls; Peter De Jonghe
Journal:  Neurology       Date:  2013-10-09       Impact factor: 9.910

View more
  7 in total

1.  A Recurrent De Novo PACS2 Heterozygous Missense Variant Causes Neonatal-Onset Developmental Epileptic Encephalopathy, Facial Dysmorphism, and Cerebellar Dysgenesis.

Authors:  Heather E Olson; Nolwenn Jean-Marçais; Edward Yang; Delphine Heron; Katrina Tatton-Brown; Paul A van der Zwaag; Emilia K Bijlsma; Bryan L Krock; E Backer; Erik-Jan Kamsteeg; Margje Sinnema; Margot R F Reijnders; David Bearden; Amber Begtrup; Aida Telegrafi; Roelineke J Lunsing; Lydie Burglen; Gaetan Lesca; Megan T Cho; Lacey A Smith; Beth R Sheidley; Christelle Moufawad El Achkar; Phillip L Pearl; Annapurna Poduri; Cara M Skraban; Jennifer Tarpinian; Addie I Nesbitt; Dietje E Fransen van de Putte; Claudia A L Ruivenkamp; Patrick Rump; Nicolas Chatron; Isabelle Sabatier; Julitta De Bellescize; Laurent Guibaud; David A Sweetser; Jessica L Waxler; Klaas J Wierenga; Jean Donadieu; Vinodh Narayanan; Keri M Ramsey; Caroline Nava; Jean-Baptiste Rivière; Antonio Vitobello; Frédéric Tran Mau-Them; Christophe Philippe; Ange-Line Bruel; Yannis Duffourd; Laurel Thomas; Stefan H Lelieveld; Janneke Schuurs-Hoeijmakers; Han G Brunner; Boris Keren; Julien Thevenon; Laurence Faivre; Gary Thomas; Christel Thauvin-Robinet
Journal:  Am J Hum Genet       Date:  2018-04-12       Impact factor: 11.025

Review 2.  Screening Platforms for Genetic Epilepsies-Zebrafish, iPSC-Derived Neurons, and Organoids.

Authors:  Aleksandr Shcheglovitov; Randall T Peterson
Journal:  Neurotherapeutics       Date:  2021-09-30       Impact factor: 6.088

3.  Modeling Pediatric Epilepsy Through iPSC-Based Technologies.

Authors:  Dina Simkin; Evangelos Kiskinis
Journal:  Epilepsy Curr       Date:  2018 Jul-Aug       Impact factor: 7.500

4.  Dyshomeostatic modulation of Ca2+-activated K+ channels in a human neuronal model of KCNQ2 encephalopathy.

Authors:  Dina Simkin; Kelly A Marshall; Carlos G Vanoye; Reshma R Desai; Bernabe I Bustos; Brandon N Piyevsky; Juan A Ortega; Marc Forrest; Gabriella L Robertson; Peter Penzes; Linda C Laux; Steven J Lubbe; John J Millichap; Alfred L George; Evangelos Kiskinis
Journal:  Elife       Date:  2021-02-05       Impact factor: 8.713

Review 5.  Concise Review: Stem Cell Models of SCN1A-Related Encephalopathies-Current Perspective and Future Therapies.

Authors:  Valery Zayat; Roza Szlendak; Dorota Hoffman-Zacharska
Journal:  Cells       Date:  2022-10-04       Impact factor: 7.666

Review 6.  Recent advances in epilepsy genomics and genetic testing.

Authors:  Malavika Hebbar; Heather C Mefford
Journal:  F1000Res       Date:  2020-03-12

Review 7.  WDR45, one gene associated with multiple neurodevelopmental disorders.

Authors:  Yingying Cong; Vincent So; Marina A J Tijssen; Dineke S Verbeek; Fulvio Reggiori; Mario Mauthe
Journal:  Autophagy       Date:  2021-04-12       Impact factor: 16.016

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.